MacroGenics | Kostnadene For Salg

Cost Of Sales Endring Dato
AbbVie USD 4.09B 181M 2024-03
Amgen USD 3.2B 88M 2024-03
AstraZeneca USD 2.22B 63M 2024-03
Biogen USD 542.2M 76.1M 2024-03
Bristol-Myers Squibb USD 2.93B 225M 2024-03
Daiichi Sankyo JPY 122.35B 27.61B 2023-12
Eli Lilly USD 1.67B 114.5M 2024-03
Genmab DKK 185M 59M 2024-03
Gilead Sciences USD 1.55B 59M 2024-03
J&J USD 6.51B 287M 2024-03
MacroGenics USD 2.12M 1.95M 2024-03
Merck USD 3.54B 200M 2024-03
Pfizer USD 3.38B 3.29B 2024-03
Regeneron Pharmaceuticals USD 433.8M 83.2M 2024-03
Roche Holding CHF 7.62B 1.33B 2023-06



MacroGenics Kostnadene For Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.